Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Genomic and mobility data reveal mass population movement as a driver of SARS-CoV-2 dissemination and diversity in Bangladesh

Lauren A. Cowley, Mokibul Hassan Afrad, Sadia Isfat Ara Rahman, Md. Mahfuz-Al-Mamun, Taylor Chin, Ayesha Mahmud, Mohammed Ziaur Rahman, Mallick Masum Billah, Manjur Hossain Khan, Sharmin Sultana, Tilovatul Khondaker, Stephen Baker, Nandita Banik, Ahmed Nawsher Alam, Kaiissar Mannor, Sayera Banu, Anir Chowdhury, Meerjady Sabrina Flora, Nicholas R. Thomson, View ORCID ProfileCaroline O. Buckee, Firdausi Qadri, Tahmina Shirin
doi: https://doi.org/10.1101/2021.01.05.21249196
Lauren A. Cowley
1Department of Biology and Biochemistry, University of Bath, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mokibul Hassan Afrad
2International Centre for Diarrheal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sadia Isfat Ara Rahman
3International Centre for Diarrheal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Md. Mahfuz-Al-Mamun
4Institute for Developing Science and Health Initiatives, Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Taylor Chin
5Center for Communicable Disease Dynamics, Dept of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA 02115, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ayesha Mahmud
6Department of Demography, University of California, Berkeley, CA 94703, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohammed Ziaur Rahman
7International Centre for Diarrheal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mallick Masum Billah
8Institute of Epidemiology, Disease Control and Research (IEDCR), Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manjur Hossain Khan
9Institute of Epidemiology, Disease Control and Research (IEDCR), Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sharmin Sultana
10Institute of Epidemiology, Disease Control and Research (IEDCR), Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tilovatul Khondaker
11Institute of Epidemiology, Disease Control and Research (IEDCR), Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Baker
12Department of Medicine, University of Cambridge, Cambridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nandita Banik
13Institute of Epidemiology, Disease Control and Research (IEDCR), Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ahmed Nawsher Alam
14Institute of Epidemiology, Disease Control and Research (IEDCR), Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kaiissar Mannor
15Institute for Developing Science and Health Initiatives, Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sayera Banu
16International Centre for Diarrheal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anir Chowdhury
17Aspire to Innovate (a2i) Program, ICT Division/Cabinet Division, Government of Bangladesh/UNDP, Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meerjady Sabrina Flora
18Directorate General of Health Services, Mohakhali, Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas R. Thomson
19Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK; London School of Hygiene and Tropical Medicine, Keppel St, Bloomsbury, London WC1E 7HT, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caroline O. Buckee
20Center for Communicable Disease Dynamics, Dept of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA 02115, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Caroline O. Buckee
Firdausi Qadri
21International Centre for Diarrheal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh
22Institute for Developing Science and Health Initiatives, Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: fqadri@icddrb.org
Tahmina Shirin
23Institute of Epidemiology, Disease Control and Research (IEDCR), Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background New data streams are being used to track the pandemic of SARS-CoV-2, including genomic data which provides insights into patterns of importation and spatial spread of the virus, as well as population mobility data obtained from mobile phones. Here, we analyse the emergence and outbreak trajectory of SARS-CoV-2 in Bangladesh using these new data streams, and identify mass population movements as a key early event driving the ongoing epidemic.

Methods We sequenced complete genomes of 67 SARS-CoV-2 samples (March-July 2020) and combined this dataset with 324 genomes from Bangladesh. For phylogenetic context, we also used 68,000 GISAID genomes collected globally. We paired this genomic data with population mobility information from Facebook and three mobile phone operators.

Findings The majority (85%) of the Bangladeshi sequenced isolates fall into either pangolin lineage B.1.36 (8%), B.1.1 (19%) or B.1.1.25 (58%). Bayesian time-scaled phylogenetic analysis predicted SARS-COV-2 first appeared in mid-February, through international introductions. The first case was reported on March 8th. This pattern of repeated international introduction changed at the end of March when three discrete lineages expanded and spread clonally across Bangladesh. The shifting pattern of viral diversity across Bangladesh is reflected in the mobility data which shows the mass migration of people from cities to rural areas at the end of March, followed by frequent travel between Dhaka and the rest of the country during the following months.

Interpretation In Bangladesh, population mobility out of Dhaka as well as frequent travel from urban hotspots to rural areas resulted in rapid country-wide dissemination of SARS-CoV-2. The strains in Bangladesh reflect the local expansion of global lineages introduced early from international travellers to and from major international travel hubs. Importantly, the Bangladeshi context is consistent with epidemiologic and phylogenetic findings globally. Bangladesh is one of the few countries in the world with a rich history of conducting mass vaccination campaigns under complex circumstances. Combining genomics and these new data streams should allow population movements to be modelled and anticipated rendering Bangladesh extremely well prepared to immunize citizens rapidly. Based on our genomics data and the country’s successful immunization history, vaccines becoming available globally will be suitable for implementation in Bangladesh while ongoing genomic surveillance is conducted to monitor for new variants of the virus.

Funding Government of Bangladesh, Bill and Melinda Gates Foundation, Wellcome Trust.

Evidence before this study The emergence of SARS-CoV-2, leading to the COVID-19 pandemic, has motivated all countries in the world to obtain high resolution data on the virus. Globally over 300,000 strains have been sequenced and information made available in GISAID. Within the first 100 days of the emergence of SARS-CoV-2, genomic analysis from different countries led to the development of vaccines which have now reached market. Information on the prevailing genotypes of SARS-CoV-2 since introduction is needed in low and middle-income countries (LMICs), including Bangladesh, in order to determine the suitability of therapeutics and vaccines in the pipeline and help vaccine deployment.

Added value of this study We sequenced SARS-CoV-2 genomes from strains that were prospectively collected during the height of the pandemic and combined these genomic data with mobility data to comprehensively describe i) how repeated international importations of SARS-CoV-2 were ultimately linked to nationwide spread, ii) 85% of strains belonged to the Pangolin lineages B.1.1, B.1.1.25 and B.1.36 and that similar mutation rates were observed as seen globally iii) the switch in genomic dynamics of SARS-CoV-2 coincided with mass migration out of cities to the rest of the country. We have assessed the contributions of population mobility on the maintenance and spread of clonal lineages of SARS-CoV-2. This is the first time these data types have been combined to look at the spread of this virus nationally.

Implications of all the available evidence SARS-CoV-2 genomic diversity and mutation rate in Bangladesh is comparable to strains circulating globally. Notably, the data on the genomic changes of SARS-CoV-2 in Bangladesh is reassuring, suggesting that immunotherapeutic and vaccines being developed globally should also be suitable for this population. Since Bangladesh already has extensive experience of conducting mass vaccination campaigns, such as the rollout of the oral Cholera vaccine, experience of developing and using new data streams will enable efficient and targeted immunization of the population in 2021 with COVID-19 vaccine(s).

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Funding: Government of Bangladesh, Bill and Melinda Gates Foundation, Wellcome Trust.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics Statement: The study protocol was approved by the Institutional Review Board (IRB) of Institute of Epidemiology, Disease Control and Research (IEDCR) (PR #IEDCR/IRB/2020/09) and icddr,b (PR #20042).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵* Joint First authors

  • ↵† Joint Senior authors

  • (l.cowley{at}bath.ac.uk)

  • (hassan.afrad{at}icddrb.org)

  • (sadia.rahman{at}icddrb.org)

  • (mahfuz{at}ideshi.org)

  • (tchin{at}hsph.harvard.edu)

  • (mahmuda{at}berkeley.edu)

  • (mzrahman{at}icddrb.org)

  • (drmasumbillah{at}yahoo.com)

  • (khanmanjur56{at}gmail.com)

  • (dr.sharmin1579{at}yahoo.com)

  • (tilovatulkhondaker{at}gmail.com)

  • (sgb47{at}medschl.cam.ac.uk)

  • (dr.nanditabanik89{at}gmail.com)

  • (anawsher{at}yahoo.com)

  • (kaiissar{at}ideshi.org)

  • (sbanu{at}icddrb.org)

  • (anir.chowdhury{at}a2i.gov.bd)

  • (meerflora{at}yahoo.com)

  • (nrt{at}sanger.ac.uk)

  • (cbuckee{at}hsph.harvard.edu)

  • (fqadri{at}icddrb.org)

  • (tahmina.shirin14{at}gmail.com)

Data Availability

Data sharing All sequence data used in this study is available on GISAID as detailed in the GISAID acknowledgements section of the supplementary material.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted January 13, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Genomic and mobility data reveal mass population movement as a driver of SARS-CoV-2 dissemination and diversity in Bangladesh
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Genomic and mobility data reveal mass population movement as a driver of SARS-CoV-2 dissemination and diversity in Bangladesh
Lauren A. Cowley, Mokibul Hassan Afrad, Sadia Isfat Ara Rahman, Md. Mahfuz-Al-Mamun, Taylor Chin, Ayesha Mahmud, Mohammed Ziaur Rahman, Mallick Masum Billah, Manjur Hossain Khan, Sharmin Sultana, Tilovatul Khondaker, Stephen Baker, Nandita Banik, Ahmed Nawsher Alam, Kaiissar Mannor, Sayera Banu, Anir Chowdhury, Meerjady Sabrina Flora, Nicholas R. Thomson, Caroline O. Buckee, Firdausi Qadri, Tahmina Shirin
medRxiv 2021.01.05.21249196; doi: https://doi.org/10.1101/2021.01.05.21249196
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Genomic and mobility data reveal mass population movement as a driver of SARS-CoV-2 dissemination and diversity in Bangladesh
Lauren A. Cowley, Mokibul Hassan Afrad, Sadia Isfat Ara Rahman, Md. Mahfuz-Al-Mamun, Taylor Chin, Ayesha Mahmud, Mohammed Ziaur Rahman, Mallick Masum Billah, Manjur Hossain Khan, Sharmin Sultana, Tilovatul Khondaker, Stephen Baker, Nandita Banik, Ahmed Nawsher Alam, Kaiissar Mannor, Sayera Banu, Anir Chowdhury, Meerjady Sabrina Flora, Nicholas R. Thomson, Caroline O. Buckee, Firdausi Qadri, Tahmina Shirin
medRxiv 2021.01.05.21249196; doi: https://doi.org/10.1101/2021.01.05.21249196

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (141)
  • Anesthesia (44)
  • Cardiovascular Medicine (408)
  • Dentistry and Oral Medicine (67)
  • Dermatology (47)
  • Emergency Medicine (141)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
  • Epidemiology (4809)
  • Forensic Medicine (3)
  • Gastroenterology (177)
  • Genetic and Genomic Medicine (670)
  • Geriatric Medicine (70)
  • Health Economics (187)
  • Health Informatics (621)
  • Health Policy (314)
  • Health Systems and Quality Improvement (200)
  • Hematology (84)
  • HIV/AIDS (155)
  • Infectious Diseases (except HIV/AIDS) (5279)
  • Intensive Care and Critical Care Medicine (325)
  • Medical Education (91)
  • Medical Ethics (24)
  • Nephrology (73)
  • Neurology (677)
  • Nursing (41)
  • Nutrition (110)
  • Obstetrics and Gynecology (124)
  • Occupational and Environmental Health (203)
  • Oncology (437)
  • Ophthalmology (138)
  • Orthopedics (36)
  • Otolaryngology (88)
  • Pain Medicine (35)
  • Palliative Medicine (15)
  • Pathology (127)
  • Pediatrics (193)
  • Pharmacology and Therapeutics (129)
  • Primary Care Research (84)
  • Psychiatry and Clinical Psychology (766)
  • Public and Global Health (1796)
  • Radiology and Imaging (321)
  • Rehabilitation Medicine and Physical Therapy (138)
  • Respiratory Medicine (255)
  • Rheumatology (86)
  • Sexual and Reproductive Health (68)
  • Sports Medicine (61)
  • Surgery (100)
  • Toxicology (23)
  • Transplantation (28)
  • Urology (37)